Impact of a care pathway for COPD on adherence to guidelines and hospital readmission: a cluster randomized trial

Purpose Current in-hospital management of exacerbations of COPD is suboptimal, and patient outcomes are poor. The primary aim of this study was to evaluate whether implementation of a care pathway (CP) for COPD improves the 6 months readmission rate. Secondary outcomes were the 30 days readmission rate, mortality, length of stay and adherence to guidelines. Patients and methods An international cluster randomized controlled trial was performed in Belgium, Italy and Portugal. General hospitals were randomly assigned to an intervention group where a CP was implemented or a control group where usual care was provided. The targeted population included patients with COPD exacerbation. Results Twenty-two hospitals were included, whereof 11 hospitals (n=174 patients) were randomized to the intervention group and 11 hospitals (n=168 patients) to the control group. The CP had no impact on the 6 months readmission rate. However, the 30 days readmission rate was significantly lower in the intervention group (9.7%; 15/155) compared to the control group (15.3%; 22/144) (odds ratio =0.427; 95% confidence interval 0.222–0.822; P=0.040). Performance on process indicators was significantly higher in the intervention group for 2 of 24 main indicators (8.3%). Conclusion The implementation of this in-hospital CP for COPD exacerbation has no impact on the 6 months readmission rate, but it significantly reduces the 30 days readmission rate.

[1]  M. Petticrew,et al.  Developing and evaluating complex interventions: the new Medical Research Council guidance , 2008, BMJ : British Medical Journal.

[2]  M. Ferri,et al.  An emergency clinical pathway for stroke patients – results of a cluster randomised trial (isrctn41456865) , 2009, BMC health services research.

[3]  M K Campbell,et al.  Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. , 2001, Statistics in medicine.

[4]  Cluster randomised trials : Methodological and ethical considerations , 2022 .

[5]  Pedro Almagro,et al.  Risk Factors for Hospital Readmission in Patients with Chronic Obstructive Pulmonary Disease , 2006, Respiration.

[6]  Thomas Rotter,et al.  Do clinical pathways enhance access to evidence-based acute myocardial infarction treatment in rural emergency departments? , 2012, The Australian journal of rural health.

[7]  M. Decramer,et al.  Eight-step method to build the clinical content of an evidence-based care pathway: the case for COPD exacerbation , 2012, Trials.

[8]  N. Santamaria,et al.  A prospective cohort study of the effectiveness of clinical pathways for the in-patient management of acute exacerbation of chronic obstructive pulmonary disease (COPD) , 2004 .

[9]  C. Roberts,et al.  Variability in the organisation and management of hospital care for COPD exacerbations in the UK. , 2007, Respiratory medicine.

[10]  T. Seemungal,et al.  COPD exacerbations: defining their cause and prevention , 2007, The Lancet.

[11]  M. Decramer,et al.  Changes in GOLD: today and tomorrow. , 2015, The Lancet Respiratory Medicine.

[12]  C. Brunelli,et al.  Liverpool Care Pathway for patients with cancer in hospital: a cluster randomised trial , 2014, The Lancet.

[13]  T. Mutsvari,et al.  Better Interprofessional Teamwork, Higher Level of Organized Care, and Lower Risk of Burnout in Acute Health Care Teams Using Care Pathways: A Cluster Randomized Controlled Trial , 2013, Medical care.

[14]  Thomas Rotter,et al.  Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. , 2010, The Cochrane database of systematic reviews.

[15]  C. Roberts,et al.  Evidence for a link between mortality in acute COPD and hospital type and resources , 2003, Thorax.

[16]  Nikolaos A. Patsopoulos,et al.  A pragmatic view on pragmatic trials , 2011, Dialogues in clinical neuroscience.

[17]  Antonella Barbieri,et al.  A cluster randomized trial to assess the impact of clinical pathways for patients with stroke: rationale and design of the Clinical Pathways for Effective and Appropriate Care Study [NCT00673491] , 2008, BMC Health Services Research.

[18]  S. Shortell,et al.  Assessing the impact of continuous quality improvement on clinical practice: what it will take to accelerate progress. , 1998, The Milbank quarterly.

[19]  J. Kimberly,et al.  The sustainability of new programs and innovations: a review of the empirical literature and recommendations for future research , 2012, Implementation Science.

[20]  M. Leal,et al.  Study of the burden on patients with chronic obstructive pulmonary disease , 2009, International journal of clinical practice.

[21]  Thomas Lee,et al.  Critical Pathways as a Strategy for Improving Care: Problems and Potential , 1995, Annals of Internal Medicine.

[22]  T. McManus,et al.  The Mater Hospital Multiprofessional Care Pathway for Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2005 .

[23]  E. Biringer,et al.  The 7-phase method to design, implement and evaluate care pathways , 2012 .

[24]  K. Nishimura,et al.  Clinical pathway for acute exacerbations of chronic obstructive pulmonary disease: method development and five years of experience , 2011, International journal of chronic obstructive pulmonary disease.

[25]  L. Manzoli,et al.  Reduced in-hospital mortality for heart failure with clinical pathways: the results of a cluster randomised controlled trial , 2009, Quality and Safety in Health Care.

[26]  R. Ali,et al.  Effect of Implementing Clinical Pathway on the Clinical Outcomes of Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease , 2014 .

[27]  M. Decramer,et al.  Inhospital management of COPD exacerbations: a systematic review of the literature with regard to adherence to international guidelines. , 2009, Journal of evaluation in clinical practice.

[28]  Marc Decramer,et al.  The impact of care pathways for exacerbation of Chronic Obstructive Pulmonary Disease: rationale and design of a cluster randomized controlled trial , 2010, Trials.

[29]  C. Roberts,et al.  European hospital adherence to GOLD recommendations for chronic obstructive pulmonary disease (COPD) exacerbation admissions , 2013, Thorax.

[30]  Steve Cunningham,et al.  Effect of an integrated care pathway on acute asthma/wheeze in children attending hospital: cluster randomized trial. , 2008, The Journal of pediatrics.

[31]  K Vanhaecht,et al.  Impact of care pathways for in-hospital management of COPD exacerbation: a systematic review. , 2011, International journal of nursing studies.

[32]  Aniza Ismail,et al.  Impact of clinical pathway on clinical outcomes in the management of COPD exacerbation , 2012, BMC Pulmonary Medicine.

[33]  D. Bratzler,et al.  Management of acute exacerbations of chronic obstructive pulmonary disease in the elderly: physician practices in the community hospital setting. , 2004, The Journal of the Oklahoma State Medical Association.

[34]  S. Gungor,et al.  The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia , 2015, International journal of chronic obstructive pulmonary disease.